Stocks Investors Can Profit From: Digital Ally, Inc. (DGLY), Coupons.Com Inc (COUP) and Aegerion Pharmaceuticals, Inc. (AEGR)

Posted by admin May 6, 2015 0 Comment 421 views

New York, NY – GDP INSIDER  –  05/06/2014.

This article discusses three companies: Digital Ally, Inc. (NASDAQ:DGLY), Coupons.Com Inc (NYSE:COUP) and Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

Digital Ally, Inc. (NASDAQ:DGLY) has been on a rollercoaster ride the last 52 weeks, with the stock dropping as low as $3.03 in July and as high as $33.59 at the beginning of September. The stock was back on the decline again yesterday dropping 9.46% or $1.71 to close at $16.36 on heavy trading of 1.6077 million shares compared with its three month average trading volume of 0.554 million. The developer and manufacturer of electronic products for law enforcement as well as home applications started to decline after it made an announcement that it will be presenting at the 16th Annual B.Riley & Co. Investor Conference on May 12, 2015. With its MACD diverging and RSI of 61, it is better to hold than buy or sell for now.

Why Should You Buy Digital Ally, Inc Shares Now? Find Out If DGLY Is The Right Investment For You From Our Free Analysis.

Coupons.Com Inc (NYSE:COUP) stock was trading down yesterday after the company reported a loss of $4 million in its first quarter for 2015. The web based promotional platform for brands and retailers closed down 7.18% or $0.85 at $10.99 on slightly above average trading volume of 0.910 million shares, compared to its three month average trading volume of 0.904 million. Coupon.Com Inc is currently trading well below its 50 day moving average of $11.59 and 200 day moving average of $14.33. With a quick ratio of 5 and RSI of 35.48, the company is all set to meet or exceed its one year price target estimate of $12.50, hold.

Where Is Coupons.Com Inc Heading? See If Coupons.Com Is Really A Bargain By Clicking Here For Free COUP Analysis.

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continued its recent downward trend yesterday with the stock declining 7.05% or $1.85 to finish the day at $21.74 on much higher than average trading volume of 2.07 million, compared to its 30 day average trading volume of 0.491 million. The biopharmaceutical company has been falling steadily for most of the last 12 months with the stock down 50.38%, but has been starting to gain back some of these losses since the beginning of the year with the stock up 3.82%. The RSI and MFI are at 21.88 and 42.23.  However, this is not a signal of a reversal and fundamentals are very uncertain.

Click Here To See How Low Aegerion Pharmaceuticals, Inc Can Still Go With Our Free AEGR Investment Analysis.

About Ultimate Stock Alerts covers NASDAQ and NYSE listed companies that are overlooked by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts text the word ULTIMATE to 555888 from your cell phone. For more information visit

Disclosure: is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment